Brainstem areas activated by diazepam withdrawal as measured by Fos-protein immunoreactivity in rats

Brain Research

Volumn 1166, Issue 1, 2007, Pages 35-46

  Fontanesi, Lucas Baptista ^a,b   Ferreira, Renata ^a,b   Cabral, Alicia ^a,b   Castilho, Vanessa Moreno ^a,b   Brandão, Marcus Lira ^a,b   Nobre, Manoel Jorge ^a,b  

^a Instituto de Neurociências and Comportamento INEC   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anxiety; Brainstem; Diazepam; dPAG; Fos; Withdrawal

Indexed keywords

BENZODIAZEPINE; DIAZEPAM; PROTEIN C FOS; SUCROSE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BRAIN; BRAIN STEM; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; DRUG DEPENDENCE; FEAR; HYPOTHALAMUS; IMMUNOREACTIVITY; INFERIOR COLLICULUS; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; SUPERIOR COLLICULUS; TEGMENTUM; WITHDRAWAL SYNDROME;

ANALYSIS OF VARIANCE; ANIMALS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DIAZEPAM; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; EXPLORATORY BEHAVIOR; FEAR; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; MOTOR ACTIVITY; PERIAQUEDUCTAL GRAY; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; SUBSTANCE WITHDRAWAL SYNDROME; TECTUM MESENCEPHALI;

ANIMALIA; RATTUS;

EID: 34547946371     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.07.007     Document Type: Article

References (81)

1. Abercrombie E.A., Keefe K.A., DiFrischia D.A., and Zigmond M.J. Differential effects of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J. Neurochem. 52 (1989) 1655-1658
2. Allison C., and Pratt J.A. Neuroadaptative processes in GABAergic and glutamatergic systems in benzodiazepine dependence. Pharmacol. Ther. 98 (2003) 171-195
3. Andrews N., File S.E., Fernandes C., Gonzalez L.E., and Barnes N.M. Evidence that the median raphe nucleus-dorsal hippocampal pathway mediates diazepam withdrawal-induced anxiety. Psychopharmacology (Berl) 130 (1997) 228-234
4. Ashton H. The diagnosis and management of benzodiazepine dependence. Curr. Opin. Psychiatry 18 (2005) 249-255
5. Azuma M., and Chiba T. Afferent projections of the infralimbic cortex (area 25) in rats: a WGA-HRP study. Kaibogaku Zasshi 71 (1996) 523-540
6. Bateson A.N. Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal. Curr. Pharm. Des. 8 (2002) 5-21
7. Beck C.H., and Fibiger H.C. Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: with and without diazepam pretreatment. J. Neurosci. 15 (1995) 709-720
8. Beckett S.R., Duxon M.S., Aspley S., and Marsden C.A. Central c-fos expression following 20 kHz/ultrasound induced defence behaviour in the rat. Brain Res. Bull. 42 (1997) 421-426
9. Borlikova G.G., Merrer J.L., and Stephens D.N. Previous experience of ethanol withdrawal increases withdrawal induced c-fos expression in limbic areas, but not withdrawal-induced anxiety and prevents withdrawal-induced elevations in plasma corticosterone. Psychopharmacology 185 (2006) 188-200
10. Brandão M.L., Anseloni V.Z., Pandossio J.E., De Araujo J.E., and Castilho V.M. Neurochemical mechanisms of the defensive behavior in the dorsal midbrain. Neurosci. Biobehav. Rev. 23 (1999) 863-875
11. Brandão M.L., Troncoso A.C., de Souza Silva M.A., and Huston J.P. The relevance of neuronal substrates of defense in the midbrain tectum to anxiety and stress: empirical and conceptual considerations. Eur. J. Pharmacol. 463 (2003) 225-233
12. Brandão M.L., Borelli K.G., Nobre M.J., Santos J.M., Albrechet-Souza L., Oliveira A.R., and Martinez R.C. Gabaergic regulation of the neural organization of fear in the midbrain tectum. Neurosci. Biobehav. Rev. 29 (2005) 1299-1311
13. Bullitt E. Expression of c-fos -like protein as a marker for neuronal activity following noxious stimulation in the rat. J. Comp. Neurol. 296 (1990) 517-530
14. Busto U.E., and Sellers E.M. Anxiolytics and sedative/hypnotics dependence. Br. J. Addict. 86 (1991) 1647-1652
15. Busto U., Sellers E.M., Naranjo C.A., Cappell H.D., Sanchez-Craig M., and Simpkins J. Patterns of benzodiazepine abuse and dependence. Br. J. Addict. 81 (1986) 87-94
16. Cabral A., Isoardi N., Salum C., Macedo C.E., Nobre M.J., Molina V.A., and Brandão M.L. Fear state induced by ethanol withdrawal may be due to the sensitization of the neural substrates of aversion in the dPAG. Exp. Neurol. 200 (2006) 200-208
17. Campeau S., Falls W.A., Cullinan W.E., Helmreich D.L., Davis M., and Watson S.J. Elicitation and reduction of fear: behavioural and neuroendocrine indices and brain induction of the immediate-early gene c-fos. Neuroscience 78 (1997) 1087-1104
18. Canteras N.S., and Goto M. Fos-like immunoreactivity in the periaqueductal gray of rats exposed to a natural predator. NeuroReport 10 (1999) 413-418
19. Canteras N.S., and Swanson L.W. The dorsal premammillary nucleus: an usual component of the mammillary body. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 10089-10093
20. Canteras N.S., Chiavegatto S., Valle L.E., and Swanson L.W. Severe reduction of rat defensive behavior to a predator by discrete hypothalamic chemical lesions. Brain Res. Bull. 44 (1997) 297-305
21. Charney D.S., Grillon C., and Bremner J.D. The neurobiological basis of anxiety and fear: Circuits, mechanisms and neurochemical interactions (part I). Neuroscientist 4 (1998) 35-44
22. Chouinard G. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. J. Clin. Psychiatry 65 Suppl 5 (2004) 7-12
23. Conde F., Audinat E., Maire-Lepoivre E., and Crepel F. Afferent connections of the medial frontal cortex of the rat. A study using retrograde transport of fluorescent dyes. I. Thalamic afferents. Brain Res. Bull. 24 (1990) 341-354
24. Dragunow M., and Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J. Neurosci. Methods 29 (1989) 261-265
25. Dunworth S.J., Mead A.N., and Stephens D.N. Previous experience of withdrawal from chronic diazepam ameliorates the aversiveness of precipitated withdrawal and reduces withdrawal-induced c-fos expression in nucleus accumbens. Eur. J. Neurosci. 12 (2000) 1501-1508
26. Emmert M.H., and Herman J.P. Differential forebrain c-fos mRNA induction by either inhalation or novelty: evidence for distinctive stress pathways. Brain Res. 845 (1999) 60-67
27. Emmett-Oglesby M.W., Spencer Jr. D.G., Elmesallamy F., and Lal H. The pentylenetetrazol model of anxiety detects withdrawal from diazepam in rats. Life Sci. 33 (1983) 161-168
28. Espejo E.F. Selective dopamine depletion within the medial prefrontal cortex induced anxiogenic-like effects in rats placed on the elevated plus-maze. Brain Res. 762 (1997) 281-284
29. Fendt M., and Fanselow M.S. The neuroanatomical and neurochemical basis of conditioned fear. Neurosci. Biobehav. Rev. 23 (1999) 743-760
30. Ferreira-Netto C., Borelli K.G., and Brandão M.L. Neural segregation of Fos-protein distribution in the brain following freezing and escape behaviors induced by injections of either glutamate or NMDA into the dorsal periaqueductal gray of rats. Brain Res. 1031 (2005) 151-163
31. File S.E. The history of benzodiazepine dependence: a review of animal studies. Neurosci. Biobehav. Rev. 14 (1990) 135-146
32. Galpern W.R., Lumpkin M., Greenblatt D.J., Shader R.I., and Miller L.G. Chronic benzodiazepine administration. VII. Behavioral tolerance and withdrawal and receptor alterations associated with clonazepam administration. Psychopharmacology (Berl) 104 (1991) 225-230
33. Gorman J.M., Kent J.M., Sullivan G.M., and Coplan J.D. Neuroanatomical hypothesis of panic disorder, revised. Am. J. Psychiatry 157 (2000) 493-505
34. Graeff F.G. Brain defense systems and anxiety. In: Roth M., Burrow G.D., and Noyes R. (Eds). Handbook of Anxiety (1990), Elsevier, New York 307-354
35. Graeff F.G. Neuroanatomy and neurotransmitter regulation of defensive behaviors and related emotions in mammals. Braz. J. Med. Biol. Res. 27 (1994) 811-829
36. Gray J.A. The Neuropsychology of Anxiety (1982), Oxford University Press, London
37. Gray J.A., and McNaughton N. The neuropsychology of anxiety. An Enquiry into Functions of the Septo-Hippocampal System. 2nd ed. (2000), Oxford University Press, London
38. Greenblatt D.J., and Shader R.I. Drug therapy. Benzodiazepines (second of two parts). N. Engl. J. Med. 291 (1974) 1239-1243
39. Griebel G., Moreau J.L., Jenck F., Misslin R., and Martin J.R. Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents. Psychopharmacology (Berl) 113 (1994) 463-470
40. Hayward M.D., Duman R.S., and Nestler E.J. Induction of the c-fos proto-oncogene during opiate withdrawal in the locus coeruleus and other regions of rat brain. Brain Res. 525 (1990) 256-266
41. Honkaniemi J., Pelto-Huikko M., Rechardt L., Isola J., Lammi A., Fuxe K., Gustafsson J.A., Wikstrom A.C., and Hokfelt T. Colocalization of peptide and glucocorticoid receptor immunoreactivities in rat central amygdaloid nucleus. Neuroendocrinology 55 (1992) 451-459
42. Imaki T., Shibasaki T., Hotta M., and Demura H. Early induction of c-fos precedes increased expression of corticotropin-releasing factor messenger ribonucleic acid in the paraventricular nucleus after immobilization stress. Endocrinology 131 (1992) 240-246
43. Jay T.M., Glowinski J., and Thierry A.M. Selectivity of the hippocampal projection to the prelimbic area of the prefrontal cortex in the rat. Brain Res. 505 (1989) 337-340
44. Jinks A.L., and McGregor I.S. Modulation of anxiety-related behaviours following lesions of the prelimbic or infralimbic cortex in the rat. Brain Res. 772 (1997) 181-190
45. Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13 (1992) 177-184
46. Koob G.F., and Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science. 278 (1997) 52-58
47. Lacerra C., Martijena I.D., Bustos S.G., and Molina V.A. Benzodiazepine withdrawal facilitates the subsequent onset of escape failures and anhedonia: influence of different antidepressant drugs. Brain Res. 819 (1999) 40-47
48. Ladewig D. Dependence liability of the benzodiazepines. Drug Alcohol Depend. 13 (1984) 139-149
49. Lamprea M.R., Cardenas F.P., Vianna D.M., Castilho V.M., Cruz-Morales S.E., and Brandão M.L. The distribution of fos immunoreactivity in rat brain following freezing and escape responses elicited by electrical stimulation of the inferior colliculus. Brain Res. 950 (2002) 186-194
50. LeDoux J.E. Emotion: clues from the brain. Annu. Rev. Psychol. 46 (1995) 209-235
51. Lingford-Hughes A., and Nutt D. Neurobiology of addiction and implications for treatment. Br. J. Psychiatry 182 (2003) 97-100
52. Li H.Y., and Sawchenko P.E. Hypothalamic effector neurons and extended circuitries activated in neurogenic stress: a comparison of footshock effects exerted acutely, chronically, and in animals with controlled glucocorticoid levels. J. Comp. Neurol. 393 (1998) 244-266
53. Lukas S.E., and Griffiths R.R. Precipitated withdrawal by a benzodiazepine receptor antagonist (Ro 15-1788) after 7 days of diazepam. Science 217 (1982) 1161-1163
54. Miller L.G., Greenblatt D.J., Roy R.B., Summer W.R., and Shader R.I. Chronic benzodiazepine administration. II. Discontinuation syndrome is associated with upregulation of gamma-aminobutyric acidA receptor complex binding and function. J. Pharmacol. Exp. Ther. 246 (1988) 177-182
55. Motzo C., Porceddu M.L., Dazzi L., Sanna A., Serra M., and Biggio G. Enhancement by flumazenil of dopamine release in the nucleus accumbens of rats repeatedly exposed to diazepam or imidazenil. Psychopharmacology 131 (1997) 34-39
56. Moy S.S., Knapp D.J., Duncan G.E., and Breese G.R. Enhanced ultrasonic vocalization and Fos protein expression following ethanol withdrawal: effects of flumazenil. Psychopharmacology (Berl) 152 (2000) 208-215
57. Owen R.T., and Tyrer P. Benzodiazepine dependence. A review of the evidence. Drugs 25 (1983) 385-398
58. Paxinos, G., Watson, C. 2005. The Rat Brain in Stereotaxic Coordinates. First Ed. Third edn. New York: Academic Press.
59. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14 (1985) 149-167
60. Persico A.M., Schindler C.W., Zaczek R., Brannock M.T., and Uhl G.R. Brain transcription factor gene expression, neurotransmitter levels, and novelty response behaviors: alterations during rat amphetamine withdrawal and following chronic injection stress. Synapse 19 (1995) 212-227
61. Petursson H., and Lader M.H. Withdrawal from long-term benzodiazepine treatment. Br. Med. J. (Clin. Res. Ed) 283 (1981) 643-645
62. Petursson H., and Lader M.H. Benzodiazepine dependence. Br. J. Addict. 76 (1981) 133-145
63. Reiman E.M., Raichle M.E., Robins E., Mintun M.A., Fusselman M.J., Fox P.T., Price J.L., and Hackman K.A. Neuroanatomical correlates of a lactate-induced anxiety attack. Arch. Gen. Psychiatry 46 (1989) 493-500
64. Richard D., Rivest S., and Rivier C. The 5-hydroxytryptamine agonist fenfluramine increases Fos-like immunoreactivity in the brain. Brain Res. 594 (1992) 131-137
65. Risold P.Y., and Swanson L.W. Structural evidence for functional domains in the rat hippocampus. Science 272 (1996) 1484-1486
66. Rosebush P.I., and Mazurek M.F. Catatonia after benzodiazepine withdrawal. J. Clin. Psychopharmacol. 16 (1996) 315-319
67. Rosen J.B., and Schulkin J. From normal fear to pathological anxiety. Psychol. Rev. 105 (1998) 325-350
68. Rynn M.A., and Brawman-Mintzer O. Generalized anxiety disorder: acute and chronic treatment. CNS Spectr. 9 (2004) 716-723
69. Sandner G., Di Scala G., Rocha B., and Angst M.J. C-fos immunoreactivity in the brain following unilateral electrical stimulation of the dorsal periaqueductal gray in freely moving rats. Brain Res. 573 (1992) 276-283
70. Sandner G., Oberling P., Silveira M.C., Di Scala G., Rocha B., Bagri A., and Depoortere R. What brain structures are active during emotions? Effects of brain stimulation elicited aversion on c-fos immunoreactivity and behavior. Behav. Brain Res. 58 (1993) 9-18
71. Schleimer S.B., Johnston G.A., and Henderson J.M. Novel oral drug administration in an animal model of neuroleptic therapy. J. Neurosci. Methods 146 (2005) 159-164
72. Senba E., Matsunaga K., Tohyama M., and Noguchi K. Stress-induced c-fos expression in the rat brain: activation mechanism of sympathetic pathway. Brain Res. Bull. 31 (1993) 329-344
73. Silveira M.C., Sandner G., and Graeff F.G. Induction of Fos immunoreactivity in the brain by exposure to the elevated plus-maze. Behav. Brain Res. 56 (1993) 115-118
74. Silveira M.C., Sandner G., Di Scala G., and Graeff F.G. c-Fos immunoreactivity in the brain following electrical or chemical stimulation of the medial hypothalamus of freely moving rats. Brain Res. 674 (1995) 265-274
75. Singewald N., and Sharp T. Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry. Neuroscience 98 (2000) 759-770
76. Smith W.J., Stewart J., and Pfaus J.G. Tail pinch induces fos immunoreactivity within several regions of the male rat brain: effects of age. Physiol. Behav. 61 (1997) 717-723
77. Stone E.A., Zhang Y., John S.M., and Bing G. c-Fos response to administration of catecholamines into brain by microdialysis. Neurosci. Lett. 133 (1991) 33-35
78. Souza-Pinto L.F., Castilho V.M., Brandão M.L., and Nobre M.J. The blockade of AMPA-kainate and NMDA receptors in the dorsal periaqueductal gray reduces the effects of diazepam withdrawal in rats. Pharmacol. Biochem. Behav. 87 (2007) 250-257
79. Toki S., Saito T., Hatta S., and Takahata N. Diazepam physical dependence and withdrawal in rats is associated with alteration in GABAA receptor function. Life Sci. 59 (1996) 1631-1641
80. Vianna D.M., Borelli K.G., Ferreira-Netto C., Macedo C.E., and Brandão M.L. Fos-like immunoreactive neurons following electrical stimulation of the dorsal periaqueductal gray at freezing and escape thresholds. Brain Res. Bull. 62 (2003) 179-189
81. Woods J.H., Katz J.L., and Winger G. Abuse liability of benzodiazepines. Pharmacol. Rev. 39 (1987) 251-413